Nuveen Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.57M | Hold |
89,566
| – | – | ﹤0.01% | 2279 |
|
|
2024
Q3 | $3.46M | Hold |
89,566
| – | – | ﹤0.01% | 2164 |
|
|
2024
Q2 | $2.88M | Buy |
89,566
+796
| +0.9% | +$25.6K | ﹤0.01% | 2205 |
|
|
2024
Q1 | $3.45M | Sell |
88,770
-3,559
| -4% | -$138K | ﹤0.01% | 2152 |
|
|
2023
Q4 | $2.84M | Buy |
92,329
+922
| +1% | +$28.4K | ﹤0.01% | 2249 |
|
|
2023
Q3 | $2.04M | Sell |
91,407
-1,300
| -1% | -$29.1K | ﹤0.01% | 2286 |
|
|
2023
Q2 | $1.99M | Sell |
92,707
-77,833
| -46% | -$1.67M | ﹤0.01% | 2348 |
|
|
2023
Q1 | $4.09M | Sell |
170,540
-87,869
| -34% | -$2.11M | ﹤0.01% | 1999 |
|
|
2022
Q4 | $6M | Buy |
258,409
+9,141
| +4% | +$212K | ﹤0.01% | 1814 |
|
|
2022
Q3 | $3.99M | Sell |
249,268
-2,781
| -1% | -$44.5K | ﹤0.01% | 2028 |
|
|
2022
Q2 | $4.47M | Buy |
252,049
+2,149
| +0.9% | +$38.1K | ﹤0.01% | 2019 |
|
|
2022
Q1 | $4.81M | Sell |
249,900
-770
| -0.3% | -$14.8K | ﹤0.01% | 2079 |
|
|
2021
Q4 | $4.68M | Sell |
250,670
-8,614
| -3% | -$161K | ﹤0.01% | 2162 |
|
|
2021
Q3 | $5.12M | Sell |
259,284
-34,428
| -12% | -$680K | ﹤0.01% | 2197 |
|
|
2021
Q2 | $6.94M | Buy |
293,712
+26,265
| +10% | +$621K | ﹤0.01% | 2076 |
|
|
2021
Q1 | $6.34M | Sell |
267,447
-819
| -0.3% | -$19.4K | ﹤0.01% | 2053 |
|
|
2020
Q4 | $5.37M | Sell |
268,266
-12,171
| -4% | -$244K | ﹤0.01% | 2036 |
|
|
2020
Q3 | $5.84M | Sell |
280,437
-8,120
| -3% | -$169K | ﹤0.01% | 1839 |
|
|
2020
Q2 | $5.05M | Buy |
288,557
+11,509
| +4% | +$201K | ﹤0.01% | 1894 |
|
|
2020
Q1 | $4.52M | Buy |
277,048
+13,748
| +5% | +$224K | ﹤0.01% | 1765 |
|
|
2019
Q4 | $5.42M | Buy |
263,300
+23,475
| +10% | +$483K | ﹤0.01% | 1952 |
|
|
2019
Q3 | $2.75M | Buy |
239,825
+40,466
| +20% | +$465K | ﹤0.01% | 2253 |
|
|
2019
Q2 | $2.62M | Buy |
+199,359
| New | +$2.62M | ﹤0.01% | 2299 |
|